A 38-year-old man is referred for evaluation of a 1.5-cm, tender, nonhealing lesion located on the back of his head. The lesion was misdiagnosed in the ED as an abscess; when lanced, ED clinicians discovered a solid mass. What is the best diagnosis for this case?
Immune-related adverse events were associated with improved survival outcomes.
Margareth Pierre-Louis, MD, MBA, FAAD discusses issues pertaining to skin cancer in people with skin of color as well as recommendations for the provision of multi-ethnic dermatology care.
The main genetic and epigenetic findings of melanomas and their pathologic and therapeutic significance is reviewed.
Experts outline treatment options and make recommendations.
A new poll shows that only about 30% of American adults say they are concerned about developing skin cancer — even though nearly 70% have at least one risk factor for the disease.
PET-CT results led to management changes in 15% of patients.
Barriers to health care access, especially cost, are associated with increased odds of not having an annual physician skin examination (PSE) among young melanoma survivors.
In patients with melanoma and confirmed progression on a PD-1, lenvatinib plus pembrolizumab demonstrated clinically meaningful responses.
Rates of relapse-free and overall survival were high as well, exceeding 90%.
